UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA

Clinical trials for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Completed 3 Terminated 1

New chemo combo targets Hard-to-Treat liver cancer

Disease control Terminated

This early-phase trial tested a two-step chemotherapy approach for people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be surgically removed. First, patients received a standard chemo mix (mFOLFIRINOX) through the veins. Then, they got a second chemo …

Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA

Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA

Get alerted when new UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA trials appear

New chemo combo targets Hard-to-Treat liver cancer